Skip to main content

NHLBI Archives

Fishing for heart attack repair tools

Jan. 5, 2012—Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool: zebrafish. The researchers visually screened...

Read more


Meds’ benefits differ in dialysis patients

Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...

Read more


Move out, cholesterol

Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.

Read more


Lung disorder drug regimen found harmful

Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.

Read more


Supplements don’t help lung injury patients

Oct. 13, 2011—Supplements did not improve outcomes of patients with acute lung injury.

Read more


Gene ups risk for needing pacemaker

Apr. 1, 2011—Researchers have identified a gene that increases the risk for developing sick sinus syndrome – the most common cause for implanting a cardiac pacemaker.

Read more


Smell test tells disorders apart

Mar. 17, 2011—Patients with certain autonomic nervous system disorders have impaired odor identification, which could aid in diagnosis.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more